Combined analysis of circulating tumor DNA and tumor tissue to overcome osimertinib resistance (OSIRIS); the second line osimertinib cohort.
Saved in:
| Title: | Combined analysis of circulating tumor DNA and tumor tissue to overcome osimertinib resistance (OSIRIS); the second line osimertinib cohort. |
|---|---|
| Authors: | van der Wel, J.W.T.1 (AUTHOR), Jebbink, M.1 (AUTHOR), van den Broek, D.2 (AUTHOR), Steinbusch, L.C.1,3 (AUTHOR), Theelen, W.S.M.E.1 (AUTHOR), Ruiter, G.1 (AUTHOR), Buikhuisen, W.1 (AUTHOR), Burgers, J.A.1 (AUTHOR), Baas, P.1 (AUTHOR), Vermeulen, M.4 (AUTHOR), van der Noort, V.4 (AUTHOR), Hashemi, S.M.S.5 (AUTHOR), Bosch, L.J.W.6 (AUTHOR), Monkhorst, K.6 (AUTHOR), Smit, E.F.1,3 (AUTHOR), Boelens, M.C.1,6 (AUTHOR), de Langen, A.J.1 (AUTHOR) j.d.langen@nki.nl |
| Source: | Lung Cancer (01695002). Dec2024, Vol. 198, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 01695002 |
|---|---|
| DOI: | 10.1016/j.lungcan.2024.107972 |
